Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 817 results for "pfizer drugmaker pfizer"

Bristol-Myers Squibb and Pfizer Inc.'s Bet on This Small Biotech Stock Could Pay Off
Motley Fool

Pfizer Reports Results From Phase 3 Trial Evaluating Pregabali...

Drugmaker Pfizer Inc. (PFE: Quote) announced top-line results from a double-blind Phase 3 study evaluating pregabalin controlled-release (CR) formulation in adult patients with postherpetic neuralgia (pain after shingles or PHN). The results ..., 2 days ago

14 images for pfizer drugmaker pfizer

Pharmaceutical Technology, 1 week ago
The New Age Online, 1 week ago
Business Insider, 1 month ago
Reuters India, 1 month ago
New Europe, 1 month ago
Citybizlist, 1 month ago, 1 month ago
Aurora Sentinel, 1 month ago
ABC News, 1 month ago
Pharmaceutical Technology, 1 month ago

Pfizer, Inc. Invests in Growth... Literally

Source: Pfizer Pfizer Inc . ( NYSE: PFE ) locked up commercial rights to Opko Health 's ( NYSE: OPK ) long-lasting human growth hormone in a deal worth hundreds of millions of dollars. The agreement helps insulate Pfizer's existing HGH ...
 Motley Fool3 days ago OPKO Health leaps on potential $570 million deal with Pfizer  Pharma Letter5 days ago
Motley Fool

Pfizer Boosts Dividend

Drugmaker Pfizer Inc. (PFE: Quote) on Monday declared a $0.28 per share first quarter 2015 dividend on its common stock, payable on March 3, 2015, to shareholders of record on February 6, 2015. Pfizer increased the dividend by about 8%, to $0.28 ...
 RTTNews.com5 days ago 3 Dividend Stocks Better Than Pfizer, Inc.  Motley Fool1 month ago
Latinos Health

Pfizer bets on gene therapy as technology comes of age

LONDON, Dec 8 (Reuters) - Pfizer Inc is moving into the gene therapy space in the latest sign that the technology for fixing faulty genes may finally be ready for prime time, following earlier setbacks. The U.S. drugmaker said on Monday it was ...
 CNBC1 week ago Pfizer buys into gene therapy's renaissance and bets on Spark Therapeutics  FierceBiotech1 week ago Pfizer bets on gene therapy coming of age  Bangalore Mirror1 week ago Pfizer Bets on Gene Therapy with Spark Therapeutics Deal  Pharmaceutical Manufacturing Magazine1 week ago
Finance 24

UK drugmakers back in spotlight as bidders free to return

Restrictions on Pfizer and Stryker reviving their bid interest in AstraZeneca and Smith & Nephew will expire
 Yahoo! UK and Ireland4 weeks ago Pfizer: No new bid likely for AstraZeneca  Finance 241 month ago Pfizer Looks to Targets Beyond AstraZeneca  FOXBusiness.com1 month ago AstraZeneca not only target for Pfizer  IOL1 month ago

AstraZeneca's anti-Pfizer growth promises? At least one big investor is buying

When Pfizer ($PFE) and Merck KGaA announced their big immuno-oncology deal Monday, market watchers immediately started extrapolating. The tie-up means Pfizer won't come back for another try at AstraZeneca ($AZN), some say. But others figure that ...
 FiercePharma1 month ago Pfizer signs $3 billion cancer deal  Pharmafocus1 month ago Pfizer, Germany's Merck KgaA Collaborate To Develop Cancer Drug - Update  RTTNews.com1 month ago German Merck, Pfizer in immunotherapy deal  CNBC1 month ago

Merck Collaboration Rules Out AstraZeneca Acquisition--For Now

Summary Pfizer's multi-billion dollar agreement with Merck excludes either drugmaker from collaborating with other companies on the drug. This class of drugs happens to be one of AstraZeneca's main focuses. The collaboration is a risk for Pfizer, ...
 Seeking Alpha4 weeks ago UPDATE 1-Pfizer dampens Astra bid hopes by signing German Merck cancer deal  CNBC1 month ago Pfizer ends Astra bid hopes with Merck deal  Irish Examiner1 month ago Pfizer signs deal with Merck  The Gulf Today1 month ago
New Europe

Pfizer, German drugmaker Merck partner on finding, developing immune-boosting cancer medicines

NEW YORK Pfizer says it will partner with German drug and chemical maker Merck in developing potential cancer drugs in a hot new medication class that harnesses the body's immune system to fight cancer. Under their agreement, New York-based ...
 FOXBusiness.com1 month ago US, German drugmakers team up on cancer medicines  Yahoo! UK and Ireland1 month ago U.S., German drugmakers team up on cancer medicines  Japan Today1 month ago
Pharmaceutical Technology

Pfizer agrees to supply contraceptive Sayana Press in poorer countries

US-based drugmaker Pfizer has signed an agreement with Bill & Melinda Gates Foundation and Children's Investment Fund Foundation (CIFF) to expand access to its injectable contraceptive, Sayana Press (medroxyprogesterone acetate), for women in poorer ...
 Pharmaceutical Technology1 month ago Pfizer, Gates Foundation, expand contraceptive access in poor nations  Yahoo! India1 month ago Low-cost and simple contraceptives for poor countries  The Africa Report1 month ago Pfizer, Bill and Melinda Gates Foundation, expand contraceptive access in poor nations  DNA India1 month ago

AstraZeneca On Track To Return To Growth By 2017, Confident Of Pipeline

UK-based drugmaker AstraZeneca Plc. (AZN.L,AZN: Quote), which earlier this year rejected an offer from US-based Pfizer Inc. (PFE), Tuesday said it is on track to return to growth by 2017, and that its pipeline is expected to drive strong and ...
 RTTNews.com1 month ago AstraZeneca boss sees new Pfizer offer as less likely  Invezz1 month ago AstraZeneca Is Building Value Without Pfizer, CEO Says  Bloomberg1 month ago AstraZeneca PLC Is Building Value Without Pfizer: CEO  BioSpace1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less